Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-18-037808

Options or other derivatives

  • Director acquired 9,600 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kiener Peter A Director 2018-06-12 Option exercise · Stock Option (right to buy) +9,600 9,600 D: show line 1 in the form
Loading xslF345X03/doc4.xml…